If you're comparing hormone replacement therapy options, the price swing between formats is bigger than most people expect. Compounded hormone therapy tends to average somewhere around $70 a month with insurance and $90 a month self-pay, while pellets, marketed as the lowest-maintenance option, typically run about $1,500 a year out of pocket because insurance rarely touches them. Patches, creams, gels, and pellets all deliver hormones differently, and that difference shows up directly in what you pay, how often you see a provider, and whether your insurance plan covers any of it.
Every figure below comes from third-party pricing research and varies by the specific hormone, your dosage, your location, and your insurance plan. None of these numbers are a quote or a guarantee. Think of them as a starting point for the conversation you'll have with a pharmacist or provider once you know which delivery method fits your life.
Patches, Cost, Visit Frequency and Insurance
Estradiol patches tend to average around $55 a month with insurance and about $60 a month self-pay. Once you factor in brand versus generic, the spread widens considerably. Generic patches generally fall between $36 and $57 a month, while brand-name patches like Vivelle-Dot and Menostar can run $158 to $166 a month for the same basic function.
Insurance status changes the math even more than brand does. Patients with coverage often pay under $40 a month for patches, but without insurance that same prescription can climb past $250 a month. That's a meaningful gap for a product that otherwise works the same way regardless of what you paid for it.
Visit frequency is one of the patch format's biggest advantages. You apply a new patch at home on a weekly or biweekly schedule depending on the product, and there's no procedure or office visit tied to the application itself. Your ongoing costs are almost entirely the prescription price, plus whatever monitoring your provider recommends separately.
Creams and Gels, Cost, Visit Frequency and Insurance
Manufactured estradiol gel averages about $142 a month with insurance and $223 a month self-pay, a gap wide enough that it's worth asking your pharmacy for both numbers before you fill anything. Vaginal cream shows an even bigger split between generic and brand: generic vaginal estradiol cream runs around $13, while brand-name Estrace vaginal cream averages closer to $115 for a comparable prescription.
Compounded hormone therapy, which includes many cream formulations, averages around $70 a month with insurance and $90 a month self-pay across delivery forms. That's often less than manufactured brand products, though compounded prescriptions come with the Medicare coverage exclusion covered further down.
Testosterone creams and gels sit in their own pricing lane. A 30-day supply typically runs about $45, rising to $100 or more for a 90-day supply, and testosterone products are generally not covered by insurance regardless of whether you're using them for men's or women's hormone therapy. As with patches, creams and gels are self-applied daily at home, so there's no procedure visit built into the routine, just the ongoing prescription cost and whatever lab monitoring your provider schedules.
Pellets, Cost, Visit Frequency and Insurance
Hormone pellets for women average around $1,500 a year. Because pellets as a category are not FDA-approved in the way patches, creams, and pills are, insurance carriers typically don't cover them, which pushes that entire cost onto the patient. Men's testosterone pellets follow a different pattern, running up to $1,000 every three months in some pricing data, though that figure varies significantly by provider and dosing protocol.
Pellets are inserted in the provider's office rather than applied at home. Once inserted, they release hormones continuously for three to six months before you need a re-insertion visit. That schedule is one of the format's main selling points if you'd rather not think about a daily or weekly routine.
What's less clear from available pricing data is what the re-insertion procedure itself costs as a separate line item. The $1,500 annual figure represents a total, not a broken-out office fee, so if you're pricing pellets against another format, ask your provider directly what the procedure visit costs on top of the pellet itself. That number varies by provider and isn't standardized across the industry.
Cost comparisons between men's testosterone pellet therapy and women's menopausal pellet therapy remain thin in the pricing research available. Only a couple of sources touch on men's pellet costs at all, and neither offers the kind of detailed side-by-side breakdown you'd want for a real comparison. Treat any men's-versus-women's pellet pricing you see as a rough starting point that depends heavily on your provider and your specific treatment plan, not a fixed rule.
Compounded Versus Manufactured Products and Medicare Coverage
If you're on Medicare, this is the section to read closely: Medicare never covers compounded bioidentical hormones. That's a flat exclusion, not a coverage tier or a prior authorization hurdle, so if your treatment plan relies on a compounding pharmacy, you should plan on paying that cost yourself regardless of your Medicare plan.
For commercial insurance, generic FDA-approved estradiol pills and patches are usually placed on the lowest copay tier, often called Tier 1, in most insurance formularies. Brand-name versions of the same hormone often sit on a higher tier, and reaching a lower copay for a brand product frequently requires your provider to submit a prior authorization request first.
The dollar gap between generic and brand can be substantial. Generic conjugated estrogen pills run around $172 compared to about $215 for brand-name Premarin, a moderate difference. Generic progesterone tells a much starker story: it typically runs $12 to $18, while brand-name Prometrium can run anywhere from $497 to $936 for the same basic hormone. If your provider is comfortable with a generic equivalent, that choice alone can be the single biggest cost lever available to you.
One comparison worth flagging as unsettled: how compounding pharmacy pellet pricing stacks up against FDA-approved commercial pellet brands like Biote. Available pricing data doesn't put these two options side by side, so if you're weighing a compounded pellet against a branded one, that's a question to bring directly to your provider rather than something you can answer from published pricing alone.
Lab Monitoring and Follow Up Visit Costs Across Formats
Regardless of which delivery format you choose, plan on lab monitoring one to two times a year while you're on hormone therapy. This applies across patches, creams, gels, and pellets alike, since the point of the monitoring is tracking your hormone levels and overall safety, not verifying a specific delivery method.
Saliva or dried urine hormone testing averages around $150 per test and typically isn't covered by insurance, so that's a cost that sits entirely outside your monthly medication price. Most patients also attend one or two follow-up visits per year no matter which format they're using, and those visits carry their own separate cost from your provider or clinic.
It's worth being clear-eyed about what the headline monthly cost figures actually include. Consultations, baseline bloodwork, and follow-up visits generally sit outside the medication price you see quoted anywhere. No source in the available pricing research combines medication cost, initial consultation, lab work, and follow-ups into a single first-year total, which means that combined number varies by provider and isn't something you can reliably estimate from monthly medication pricing alone. If you want a real sense of your total first-year cost, ask your provider to walk through each of these components separately rather than assuming the medication price is the whole picture.
Lowering Out of Pocket Costs
Here's a detail that surprises a lot of patients: your insurance copay isn't always the cheapest option. Cash price at the pharmacy sometimes beats what you'd pay through insurance, so it's worth asking for both numbers before you fill a prescription rather than assuming coverage automatically means a lower price.
This isn't hypothetical. Manufactured estradiol gel costs less with insurance ($142) than self-pay ($223), which is what you'd expect. But the vaginal ring flips that pattern, running higher with insurance listed at $172 than the self-pay figure of $162 in the same pricing data. That inconsistency means insurance status alone doesn't reliably predict which price is lower for a given product. Always ask for the cash price alongside your copay.
Some of the per-product pricing you'll find online, including the generic-versus-brand figures cited earlier, reflects discount-card rates from services like GoodRx and Drugs.com rather than the retail price posted at the pharmacy counter. That means the actual quote you get when you show up to fill a prescription may differ from published estimates, sometimes in your favor if you present a discount card, sometimes not.
Savings cards and patient assistance programs can meaningfully reduce out-of-pocket costs for branded products specifically, since manufacturers often subsidize their own brand-name drugs to compete with generics. If your provider has prescribed a brand-name product and the price feels high, ask whether a manufacturer savings card applies before assuming you're stuck with the sticker price.
Which Format Fits Your Situation
Patches make the most sense if you want predictable, low-effort self-management and the broadest insurance support. Generic patches sit on the lowest formulary tiers for most commercial plans, and the weekly or biweekly home routine means no procedure visits eating into your schedule.
Creams and gels suit patients who want daily dosing flexibility, letting you adjust more precisely day to day. The tradeoff is that brand-name self-pay pricing for gels and creams runs among the highest of the manufactured options, so this format rewards sticking with a generic version if your provider offers one.
Pellets fit best if you strongly prefer to avoid daily or weekly dosing altogether and you're comfortable budgeting roughly $1,500 a year out of pocket, since insurance rarely applies to this format. The office-visit schedule, every three to six months for re-insertion, is part of the appeal for people who don't want to think about their hormone routine between visits.
Compounded options generally cost less per month than most manufactured brand products, which makes them attractive if you don't have Medicare and your insurance treats compounded prescriptions reasonably. But the Medicare exclusion is absolute, and compounded therapy still requires the same separate lab monitoring cost as every other format.
In practice, the right format comes down to three questions: what tier your insurance formulary places your preferred hormone on, how much daily or weekly dosing you're willing to tolerate, and whether you'd rather pay cash for convenience than deal with prior authorizations or formulary restrictions. Answering those three questions with your provider, alongside a hormone consultation and the lab work your treatment plan requires, will get you a far more accurate cost picture than any published price range can offer on its own.
TL;DR: Hormone replacement therapy costs vary widely by delivery method, with compounded therapy averaging around $70 to $90 a month, patches running about $55 to $60 a month, and pellets costing roughly $1,500 a year since insurance rarely covers them, so patients should treat these figures as a starting point for a conversation with their pharmacist or provider rather than a guaranteed price.